Doxil and Gemcitabine in Recurrent Ovarian Cancer
NCT00312650
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Carcinoma
Interventions
DRUG:
liposomal doxorubicin and gemcitabine
Sponsor
Women and Infants Hospital of Rhode Island
Collaborators
[object Object]